Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Vista Pharma
Vista Pharma
BSE: 524711NSE: ISIN: INE427C01021

14th-Aug-2019 16:02Source: BSE

Vista Pharmaceuticals - Outcome of Board Meeting

With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 14th August, 2019 at 3:00 PM, at the corporate office of the Company inter-alia considered and approved the following:

1. Un-Audited Financial Results for the quarter ended 30th June, 2019.
2. Limited Review Report for the quarter ended 30th June, 2019.
3. Draft Board of Directors'' Report on the company''s activities for the financial year ended March 31st, 2019.
4. To convene the 28th Annual General Meeting of the company for the financial year 2018-19 to be held on Thursday, 19th August, 2019 at the Registered office of the Company.
5. Draft Notice for the 28th Annual General Meeting of the Members of the Company.
6. Draft Secretarial Audit Report for the financial year ended 31st March, 2019.
7. Certificate from Managing Director & Chief Financial Officer of the Company for the financial year ended 31st March, 2019.
and others

Sections
Follow us on
Available On
PCI DSS Compliant